analyst meet recap posit deliv top quartil larg cap growth
attend annual analyst meet product fair compani
mahwah nj facil much discuss mako though outlook
view remain bright instead manag focus growth driver
neurovascular trauma extrem endoscopi collect believ
categori area carri revenu growth next year
upper-quartil large-cap med-tech compani although oper
margin headwind still believ manag commit improv
top-lin strength yield roughli ep growth
deriv perspect concern commentari could hurt
believ like year away feedback embolden neutral
thesi name continu recommend investor despit premium
valuat reiter ow rate
plenti growth driver ahead manag spent lot time run
variou revenu growth driver mako still expect high singl digit knee
growth next year includ neurovascular market growth
healthi introduc lot new product trauma extrem
categori grow quickli along new product endoscopi
novadaq sport med carri day overal believ compani well
posit deliv top-quartil larg cap med-tech growth like
coupl headwind probabl push op margin expans closer bp
manag re-affirmed expect op margin expans next
year given currenc acquisit headwind would surpris see
come closer said anticip margin expans compon
stori much place yield steadi low doubl digit ep growth go
forward though manag put stake ground bottom line
deriv call rest coverag manag clear
want get bigger total sholder arthroplasti could competit headwind
believ product portfolio realli hurt latter
even believ cadenc new robot applic bi-
cruciat spar knee spine shoulder specul estim put
competit spinal system time-frame final
seen much organ chang recent believ still
ripe share loss embolden thesi simpli earli get involv
name new manag move turn compani around
stock continu next page
unexpect slowdown surgic volum price pressur
price close novemb
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
stock certainli acknowledg premium valuat share trade
compar believ momentum busi simpli strong walk
away moment thu rais price target repres
half turn increas multipl time ep believ name
deserv greater premium given increas confid upper-quartil growth profil
within larg cap med tech consequ reiter ow rate
even attend annual analyst meet product fair compani
mahwah nj campu compani reiter previou statement expect top-lin
grow similar rate expect year manag went
key growth driver includ mako meet starter leadership team
neurovascular franchis spoke dynam influenc market new product
recent introduc discuss also includ panel three thought-lead
clinician perform stroke case per year procedur growth
perspect one clinician indic practic volum growth mid-
upper teen past three year along surgeon anticip similar level
expans well data dawn trial demonstr patient treat
outsid normal hour onset period hour anticip patient
receiv endovascular care stroke next year beyond consequ anticip
overal stroke market grow low mid doubl digit next year great
backdrop head
product perspect compani introduc neuroform atla devic
deliv coil flow divert stent clinician use hybrid
approach treat larger aneurysm brain devic well receiv
introduc addit compani rel recent approv flow divert technolog
hit market along vecta syk foray aspir segment
ischem stroke categori one physician panel indic switch major
case volum away industri leader aspir syk technolog
largest diamet product market easi maneuv challeng
neurovasculatur overal view outlook neurotech franchis next year growth
readili achiev quit conserv
respect trauma extrem busi manag indic still
consider room gain share within former given continu disrupt categori
leader believ inde true capit resourc need deploy larg
number instrument set critic effect compet space
extrem side ledger manag indic introduct revers shoulder
system continu progress well disclos introduc optim stem product
dig product come month anticip find
interest among clinician fast growth categori aggreg believ compani
inde gener mid- upper singl digit growth segment busi next year
within endoscopi busi manag highlight new spi phi hand held imag
clinician meet term game changer time cover novadaq
stand alon compani would echo sentiment product much easier
clinician use separ manag indic pursu number new indic
novadaq technolog overal anticip meaning growth contributor
franchis beyond ceo kevin lobo quit enthusiast new applic
technolog next decad final compani sport medicin franchis
deliv mid- upper teen growth recent quarter believ opportun exist
continu build presenc within larg growth market go forward believ
endoscopi abl deliv upper singl digit revenu growth next year
page
lastli respect mako formal present technolog
meet howev follow convers manag indic interest
system remain brisk remain track easili exceed number system placement
year compar state major share take knee
direct result mako system number quit high
visibl compani view commentari quit compel share take
like prove sticki even get act togeth categori bottom line
anticip deliv anoth excel year knee growth overal
revenu perspect confid inde deliv revenu growth next year
model right would make one faster growth larg
profit perspect manag reiter expect bp oper
margin expans annual come year said face headwind currenc
acquisit announc would surpris see number toward
low mid point rang next year could certainli come toward high end rang
top-lin strength continu believ prudent expect type perform light
headwind believ short term durat collect manag state
expect revenu growth level next year deliv year said
meet expect high end rang least ep growth
anticip perform revenu ep growth next year said
done
final comment point deriv perspect rest
coverag univers meet today first intent improv posit
shoulder market go forward share compar could
neg futur believ product portfolio realli hurt
wright next year even opinion respect robot manag coy
time new applic mako howev state initi
program robot perform shoulder replac procedur take year
obtain believ put shoulder approv time-frame press
spine said expect indic someth rang make
sens us specul timefram
acquisit mazor like worri sever year like
next re-ent market rosa
respect continu investor concern rebound recent
issu begin hurt hip knee space fairli soon howev manag
note seen much improv organ recent
product ration discuss recent call like result disloc
consequ thesi turnaround take quit time
investor need particip stori remain intact though still like chang
new ceo make
piper jaffray act financi advisor acquisit piper jaffray
provid histor financi advisori servic hyperbranch medic technolog receiv
invest bank fee close sale
neutral pt base ep risk includ signific drop
page
million except per share data
good sold
percent sale
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
